arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2406.19346stat.MEstat.AP
收藏

通过校准贝叶斯因子从临床试验中提取先验信息

Eliciting prior information from clinical trials via calibrated Bayes factor

Roberto Macrì Demartino, Leonardo Egidi, Nicola Torelli, Ioannis Ntzoufras

AI总结:

针对贝叶斯power prior中权重参数先验分布的确定难题,提出基于模拟的校准贝叶斯因子方法,依据数据证据强度动态更新先验,有效平衡历史数据整合与先验-数据冲突,并通过模拟与真实临床试验数据验证了其性能。

摘要:

在贝叶斯框架中,power prior分布越来越多地被用于临床试验及类似研究,以纳入外部和过去的信息,通常用于为与治疗效果相关的参数提供信息。其使用在样本量较小且确实存在稳健先验信息的场景中尤为有效。该方法的一个关键组成部分是其权重参数,该参数控制着纳入当前分析的历史信息量。该参数可被视为固定的或随机的。尽管存在多种确定该参数的策略,但按照完全贝叶斯方法来提取权重参数的先验分布仍然是一个挑战。通常,应谨慎选择该参数,以准确反映可用的先验信息,同时不主导后验推断结论。为此,我们提出了一种新方法,通过基于模拟的校准贝叶斯因子程序来提取权重参数的先验分布。该方法允许根据数据提供的证据强度来更新先验分布:其目标是当历史数据与当前信息一致时促进历史数据的整合,并在出现差异(例如先验-数据冲突)时限制其整合。所提方法的性能通过模拟研究进行了测试,并应用于来自临床试验的真实数据。

英文摘要:

In the Bayesian framework power prior distributions are increasingly adopted in clinical trials and similar studies to incorporate external and past information, typically to inform the parameter associated to a treatment effect. Their use is particularly effective in scenarios with small sample sizes and where robust prior information is actually available. A crucial component of this methodology is represented by its weight parameter, which controls the volume of historical information incorporated into the current analysis. This parameter can be considered as either fixed or random. Although various strategies exist for its determination, eliciting the prior distribution of the weight parameter according to a full Bayesian approach remains a challenge. In general, this parameter should be carefully selected to accurately reflect the available prior information without dominating the posterior inferential conclusions. To this aim, we propose a novel method for eliciting the prior distribution of the weight parameter through a simulation-based calibrated Bayes factor procedure. This approach allows for the prior distribution to be updated based on the strength of evidence provided by the data: The goal is to facilitate the integration of historical data when it aligns with current information and to limit it when discrepancies arise in terms, for instance, of prior-data conflicts. The performance of the proposed method is tested through simulation studies and applied to real data from clinical trials.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑